SWX:NOVOB - Novo Nordisk A/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close€47.79
Today's RangeN/A
52-Week Range€33.43 - €56.35
VolumeN/A
Average Volume671 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive NOVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for NOVOB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Novo Nordisk A/S (SWX:NOVOB) Frequently Asked Questions

What is Novo Nordisk A/S's stock symbol?

Novo Nordisk A/S trades on the SWX under the ticker symbol "NOVOB."

What is the consensus analysts' recommendation for Novo Nordisk A/S?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novo Nordisk A/S in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Novo Nordisk A/S.

Has Novo Nordisk A/S been receiving favorable news coverage?

News stories about NOVOB stock have trended somewhat positive recently, InfoTrie reports. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Novo Nordisk A/S earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.


MarketBeat Community Rating for Novo Nordisk A/S (SWX NOVOB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  112
MarketBeat's community ratings are surveys of what our community members think about Novo Nordisk A/S and other stocks. Vote "Outperform" if you believe NOVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVOB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2019 by MarketBeat.com Staff

Featured Article: Hedge Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel